Association Study of FOS-Like Antigen-2 Promoter Polymorphisms With Papillary Thyroid Cancer in Korean Population.
	    		
		   		
	    	
    	
    	
   		
        
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		Seung Woo KIM
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Choon Dong KIM
			        		
			        		;
		        		
		        		
		        		
			        		Joo Ho CHUNG
			        		
			        		;
		        		
		        		
		        		
			        		Kee Hwan KWON
			        		
			        		
		        		
		        		
		        		
		        		
		        			
			        		
			        		Author Information
			        		
		        		
		        		
			        		
			        		
			        			1. Department of Otorhinolaryngology Head & Neck Surgery, VHS Medical Center, Seoul, Korea.
			        		
		        		
	        		
        		 
        	
        	
        	
        		- Publication Type:Original Article
 
        	
        	
        		- Keywords:
        			
	        			
	        				
	        				
			        		
				        		Papillary thyroid cancer;
			        		
			        		
			        		
				        		FOS-like antigen-2;
			        		
			        		
			        		
				        		Polymorphism
			        		
			        		
	        			
        			
        		
 
        	
            
            	- MeSH:
            	
	        			
	        				
	        				
				        		
					        		Alleles;
				        		
			        		
				        		
					        		Apoptosis;
				        		
			        		
				        		
					        		Genes, fos;
				        		
			        		
				        		
					        		Humans;
				        		
			        		
				        		
					        		Leucine Zippers;
				        		
			        		
				        		
					        		Logistic Models;
				        		
			        		
				        		
					        		Methods;
				        		
			        		
				        		
					        		Odds Ratio;
				        		
			        		
				        		
					        		Polymorphism, Single Nucleotide;
				        		
			        		
				        		
					        		Thyroid Gland*;
				        		
			        		
				        		
					        		Thyroid Neoplasms*;
				        		
			        		
				        		
					        		Transcription Factors
				        		
			        		
	        			
	        			
            	
            	
 
            
            
            	- From:Clinical and Experimental Otorhinolaryngology
	            		
	            		 2014;7(1):42-46
	            	
            	
 
            
            
            	- CountryRepublic of Korea
 
            
            
            	- Language:English
 
            
            
            	- 
		        	Abstract:
			       	
			       		
				        
				        	OBJECTIVES: FOS-like antigen-2 (FOSL-2), a member of the FOS gene family, encode leucine zipper proteins that can heterodimerize with proteins of Jun family. Thus, activating protein (AP)-1 transcription factor is formed, has a crucial role in proliferation, differentiation and apoptosis of normal tissue as well as oncogenic transformation and progression. We performed an association study of single nucleotide polymorphisms (SNPs) in the FOSL-2 with papillary thyroid cancer (PTC). We also estimated the relationships between the SNPs and the clinicopathologic characteristics of PTC. METHODS: One promoter SNPs (rs925255) of FOSL-2 gene were genotyped with direct sequencing method in 94 PTC and 213 controls. PTC patients were dichotomized and compared with respect to clinical parameters of PTC. Genetic data were analyzed using Helixtree, SNPAnalyzer, SNPStats. Multivariate logistic regression analysis was fulfilled to evaluate the genetic effect with adjustment for age and sex. RESULTS: SNP (rs925255) in FOSL-2 showed a significant association (codominant 1 model [G/G vs. A/G]: odds ratio [OR], 0.531, 95% confidence interval [CI], 0.293 to 0.96, P=0.036; dominant model: OR, 0.50, 95% CI, 0.28 to 0.89, P=0.015) with PTC. The frequency of allele G in rs925255 was also significantly associated with PTC (OR, 0.59; 95% CI, 0.34 to 0.91; P=0.02). But we fail to prove significant association between this polymorphism (rs925255) and clinico-pathological parameters. CONCLUSION: Our findings suggest that the rs925255 SNP and its allele G show significant association with the PTC in Korean population.